Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how ...
Depression affects more than 280 million people worldwide, and approximately one-third of patients with major depressive disorder fail to respond to conventional antidepressants. The search for more ...
Credit: Getty Images. A Prescription Drug User Fee Act target date of January 26th, 2024 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review ...
The Company is scheduling a meeting with the FDA to discuss the issues raised in the letter. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Defender ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback